Specifically, exosomal ADAM17 disrupts VE-cadherin-mediated adhesion, thereby increasing vascular permeability and facilitating CRC cell intravasation, CTC generation, and ultimately metastasis. Here, ADAM17 is linked to colorectal carcinoma.